← Leaderboards
Dimitris G. Placantonakis
New York University School Of Medicine
$5,377,533
Attributed
$5,695,345
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,695,345 · 6
By mechanism
R01$4,426,348 · 2
R21$1,099,497 · 3
R03$169,500 · 1
Top collaborators
- Mary Helen Barcellos-Hoff2 shared
- Thomas A Neubert2 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Philipp Leucht$5,839,743
- Soledad Cabeza De Vaca$609,575
- Piul Sanjana Rabbani$685,800
- Juliana Theresa Remark$151,127
- Deborah L Yelon$13,620,065
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroIn VivoCellsLeadMolecularPropertyTumorBrainRegulationMediatingTumor InitiationStem CellsProteinsImpairmentBaseNeoplastic CellNovel StrategiesGlioblastomaGenetic TranscriptionMalignant NeoplasmsExcisionSignal TransductionTranscription FactorXenograft Procedure
Grant awards (15)
Developmentally Regulated Enhancers and Chromatin Architecture in Human Neurogenesis$537,026
R01 · FY2025 · NS · contact PI
Developmentally Regulated Enhancers and Chromatin Architecture in Human Neurogenesis$520,916
R01 · FY2024 · NS · contact PI
Developmentally Regulated Enhancers and Chromatin Architecture in Human Neurogenesis$537,026
R01 · FY2023 · NS · contact PI
Developmentally Regulated Enhancers and Chromatin Architecture in Human Neurogenesis$554,401
R01 · FY2022 · NS · contact PI
Calcium dynamics and signaling in glioma$466,125
R21 · FY2022 · NS · contact PI
The role of GPR133 in glioblastoma$444,858
R01 · FY2022 · NS · contact PI
The role of GPR133 in glioblastoma$444,858
R01 · FY2021 · NS · contact PI
The role of GPR133 in glioblastoma$460,820
R01 · FY2020 · NS · contact PI
The role of GPR133 in glioblastoma$460,820
R01 · FY2019 · NS · contact PI
The role of GPR133 in glioblastoma$465,623
R01 · FY2018 · NS · contact PI
Metabolic aberrations in glioma initiation$84,750
R03 · FY2016 · NS · contact PI
Contextual Glioblastoma Screening For Efficacious Radiation Sensitizers$211,875
R21 · FY2015 · NS · contact PI
Metabolic aberrations in glioma initiation$84,750
R03 · FY2015 · NS · contact PI
Contextual Glioblastoma Screening For Efficacious Radiation Sensitizers$254,250
R21 · FY2014 · NS · contact PI
Diverse roles of Notch signaling in glioblastoma$167,247
R21 · FY2013 · NS · contact PI